Stock Scorecard

Stock Summary for Royalty Pharma plc - Class A (RPRX) - $53.81 as of 6/18/2026 9:10:52 AM EST

Total Score

9 out of 30

Safety Score

55 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for RPRX

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RPRX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RPRX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for RPRX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for RPRX (55 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 6
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 4
Operating Margin (Max of 10) 10
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Financial Details for RPRX

Company Overview
Ticker RPRX
Company Name Royalty Pharma plc - Class A
Country N/A
Description Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 3/31/2026
Next Earnings Date 8/5/2026

Stock Price History
Last Day Price 53.81
Price 4 Years Ago 36.11
Last Day Price Updated 6/18/2026 9:10:52 AM EST
Last Day Volume 3,128,768
Average Daily Volume 4,083,114
52-Week High 56.50
52-Week Low 33.57
Last Price to 52 Week Low 60.29%

Valuation Measures
Trailing PE N/A
Industry PE 89.13
Sector PE 54.87
5-Year Average PE 24.67
Free Cash Flow Ratio 40.77
Industry Free Cash Flow Ratio 26.45
Sector Free Cash Flow Ratio 35.97
Current Ratio Most Recent Quarter 2.66
Total Cash Per Share 1.32
Book Value Per Share Most Recent Quarter 15.53
Price to Book Ratio 3.49
Industry Price to Book Ratio 11.67
Sector Price to Book Ratio 23.90
Price to Sales Ratio Twelve Trailing Months 12.79
Industry Price to Sales Ratio Twelve Trailing Months 10.67
Sector Price to Sales Ratio Twelve Trailing Months 23.47
Analyst Buy Ratings 6
Analyst Strong Buy Ratings 3

Share Statistics
Total Shares Outstanding 443,274,000
Market Capitalization 23,852,573,940
Institutional Ownership N/A

Dividends
Ex-Dividend Date 5/15/2026
Previous Dividend Amount 0.2350
Current Dividend Amount 0.2350
Total Years Dividend Increasing 6
Trailing Annual Dividend Rate 0.91
Trailing Annual Dividend Yield 1.68%
Forward Annual Dividend Rate 0.94
Forward Annual Dividend Yield 1.73%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 2.30%
5-Year Average Dividend Yield 2.71%
1-Year Dividend Growth Rate Percentage 6.82%
3-Year Dividend Growth Rate Percentage 3.35%
5-Year Dividend Growth Rate Percentage 5.46%
All-Time Dividend Growth Rate Percentage 6.66%
Dividend Payout Ratio 47.89%

Income Statement
Quarterly Earnings Growth YOY 23.20%
Annual Earnings Growth -10.25%
Reported EPS 12 Trailing Months 1.90
Reported EPS Past Year 1.30
Reported EPS Prior Year 4.84
Net Income Twelve Trailing Months 827,598,000
Net Income Past Year 770,947,000
Net Income Prior Year 858,983,000
Quarterly Revenue Growth YOY 11.00%
5-Year Revenue Growth 2.30%
Operating Margin Twelve Trailing Months 100.30%

Balance Sheet
Total Cash Most Recent Quarter 586,395,000
Total Cash Past Year 618,696,000
Total Cash Prior Year 929,026,000
Net Cash Position Most Recent Quarter -7,990,048,000
Net Cash Position Past Year -7,952,221,000
Long Term Debt Past Year 8,570,917,000
Long Term Debt Prior Year 6,614,653,000
Total Debt Most Recent Quarter 8,576,443,000
Equity to Debt Ratio Past Year 0.43
Equity to Debt Ratio Most Recent Quarter 0.45
Total Stockholder Equity Past Year 6,476,900,000
Total Stockholder Equity Prior Year 6,946,581,000
Total Stockholder Equity Most Recent Quarter 6,888,546,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months 2,653,172,000
Free Cash Flow Per Share Twelve Trailing Months 5.99
Free Cash Flow Past Year 2,489,823,000
Free Cash Flow Prior Year 2,768,986,000

Options
Put/Call Ratio 0.03
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 1.43
MACD Signal 1.39
20-Day Bollinger Lower Band 39.31
20-Day Bollinger Middle Band 47.80
20-Day Bollinger Upper Band 56.29
Beta 0.42
RSI 65.68
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System
Modified 6/18/2026 12:25:20 AM EST